Using Nanotechnology in Medicine: Challenges & Opportunities
Can nanotechnology improve drug delivery? Allow personalization of healthcare? Help existing drugs work better? The answer is yes — some of the greatest discoveries from the lab are now making it into patients! Come learn about some of the different ways nanomedicine can improve patient care and find out how to get involved on the Northeastern University campus.
Anne L van de Ven is a Research Scientist and Instructor at Northeastern University, where she combines high throughput nanoparticle synthesis with quantitative imaging and multiscale modeling to study and optimize cancer treatment in animal models. As Assistant Director of CaNCURE and the Nanomedicine Academy, as well as Research Coordinator of the IGERT Nanomedicine program, she is highly involved in the education and training of future nanomedicine leaders. Her graduate courses in nanomedicine are attended by students across the nation as part of a pilot NSF-funded program to provide new educational resources to minority-serving institutions. Anne received her PhD in Bioengineering from Rice University in 2008. From 2009 to 2013, she developed optical techniques for real-time monitoring nanoparticle-based drug delivery and treatment response under the supervision of Dr. Mauro Ferrari. Dr. van de Ven has 12 years experience in translational nanomedicine, clinical collaboration, and preclinical experimental design. Her areas of expertise include: nanomedicine education, intravital microscopy, optical instrumentation, nanoparticle design and characterization, drug delivery, and animal models of cancer.